Skip to Sidebar Skip to Content

Prozymi Biolabs

Edinburgh biotech developing enzymes that neutralise the parts of gluten that trigger coeliac reactions.

  • Food & Agritech
  • Edinburgh
Sector
Food & Agritech
Stage
Undisclosed
Based in
Edinburgh
Founded
2021
Funding raised
Undisclosed

Prozymi Biolabs is developing naturally derived enzymes that break down the immunogenic fragments of gluten while leaving the rest of the protein intact. The aim is to let food manufacturers make wheat-based products that are safe for people with coeliac disease or gluten sensitivity, with better taste, texture and nutrition than conventional gluten-free alternatives and at lower cost. The company has worked with the University of Edinburgh on discovering and characterising gluten-degrading enzymes, received a SMART: SCOTLAND grant, and has taken part in IBioIC and University of Edinburgh incubator programmes.

Team

  • Ioannis Stasinopoulos, Co-founder and CEO LinkedIn
  • Andreas Andreou, Co-founder and CSO LinkedIn

← All UK startups · Is this your company? Request an update

More startups in the directory

Subscribe to Newsletter

Join me on this exciting journey as we explore the boundless world of web design together.